CNET – Apple, Google, Samsung to take on diabetes with wearables — report

The companies are seeking ways to integrate health sensors and apps into their wearable devices, including those to measure glucose levels in a non-invasive way.
The companies are seeking ways to integrate health sensors and apps into their wearable devices, including those to measure glucose levels in a non-invasive way.
It is not just how many hours of sleep we get a night that affects our ability to wake up early, happy and productive. All things considered, it is possible to slowly transform yourself into a morning person. Believe it or not, mornings can be the best part of your day.
A bionic pancreas whose first results in human patients were recently published in the New England Journal of Medicine, could make the statement purely factual: If you have type 1 diabetes, you will have to prick yourself once every four days or so to change out the needles in the closed-loop blood sugar monitor and […]
Fat-soluble vitamin A, which is key to a healthy immune system and strong vision, may also help battle type 2 diabetes, according to a new study.
The link between depression and mortality has often been studied in type 2 diabetes, but research of this in type 1 diabetes patients is rare, she noted.
Diabetes patients stand to benefit from two experimental insulin therapies that could eventually replace Sanofi’s global leader Lantus, according to results from large clinical trials
A Novo Nordisk drug, IDegLira which combines its long-acting insulin degludec with its type 2 diabetes treatment Victoza, maintained superior blood sugar reduction after one year.
LDL cholesterol wasn’t a good predictor of cardiovascular disease in type 1 diabetes, but the total cholesterol-to-HDL ratio appeared more reliable, an observational study showed
Peters and her co-authors described the new guidelines as filling a need in the medical community as type 1 diabetes is often grouped with type 2 diabetes in adults or considered only a pediatric disease where a fear of hypoglycemia previously mandated staged glycemic targets.
An automated “bionic” pancreas that incorporates glucagon as well as insulin has shown improved blood glucose for five consecutive days in a study of patients with type 1 diabetes.
Some diabetes experts have expressed concerns about recent national guidelines on lipid management, criticizing a lack of LDL cholesterol targets and little direction for management with drugs beyond statins
An ultra-rapid inhaled insulin that approximates glucose excursions following meals is a non-invasive, effective therapy for patients with type 1 or type 2 diabetes, according to research presented at the American Diabetes Association’s 74th Scientific Sessions.
Longtime type 1 PWD Dan Patrick, who joined us also at our 2013 DiabetesMine Innovation Summit, gives a great overview and evaluation of FRIO cooling packs for insulin storage. He’s a big fan!
Could it be that the biggest U.S. diabetes meeting of the year — focused on physicians and researchers sharing the latest medical science — has finally opened a window into the real-life struggles of us PWDs (people with diabetes)?
Combining two different medications could help patients with Type 1 diabetes at least partially regain the ability to produce their own insulin, a University of Florida study has shown.
So what was big coming out of ADA this year, from our POV? Here’s a smattering of key news, in no particular order.
If consuming your recommended two to three cups of vegetables every day feels like a chore, it’s obvious you’ve yet to tap into the artful, enchanting and exquisite potential of the edible plant.
We talk a lot about diabetes technology here in the abstract — but there’s no substitute for the real-world testimonials of the people living with this stuff attached to their bodies 24/7. Today our friend and fellow type 1 diabetes writer Dan Fleshler shares his very personal sentiments on wearing a CGM (continuous glucose monitor).
According to experts, patients under the age of 19 should try to maintain an A1C blood sugar level that’s less than 7.5 percent. A1C is a test that measures the average blood sugar (glucose) levels over the span of several months, according to a news release.
Today our weekly Ask D’Mine columnist and community educator Wil Dubois takes a look at health insurance reform from the perspective of a patient at his rural diabetes clinic. Wow.